COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.

Blood Adv · 2022 · PMC8575532 · PMID 34749396

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

marginally significantP = .075so close (0.05 < p ≤ 0.1)

Only disease status at the time of COVID-19 was marginally significant for adverse outcome ( P = .075), adjusted by sex (male vs female; P = .0092; Table 2 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.